Abel-Hall

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-06
Total Holdings
202
Total Value
165684917
Accession Number
0002013339-25-000002
Form Type
13F-HR
Manager Name
Abel-Hall
Data Enrichment
87% identified
175 identified27 unidentified

Holdings

202 positions • $165.7M total value
Manager:
Search and click to pin securities to the top
Page 11 of 11
Ovid Therapeutics Inc.
Shares:10.2K
Value:$3.2K
% of Portfolio:0.0% ($3.2K/$165.7M)
Lyra Therapeutics, Inc.
Shares:12.2K
Value:$1.5K
% of Portfolio:0.0% ($1.5K/$165.7M)